GR3030650T3 - Use of a decapeptide with a benzodiazepine activity for the preparation of medicaments and dietary supplements - Google Patents

Use of a decapeptide with a benzodiazepine activity for the preparation of medicaments and dietary supplements

Info

Publication number
GR3030650T3
GR3030650T3 GR990401736T GR990401736T GR3030650T3 GR 3030650 T3 GR3030650 T3 GR 3030650T3 GR 990401736 T GR990401736 T GR 990401736T GR 990401736 T GR990401736 T GR 990401736T GR 3030650 T3 GR3030650 T3 GR 3030650T3
Authority
GR
Greece
Prior art keywords
decapeptide
contg
leu
medicaments
preparation
Prior art date
Application number
GR990401736T
Other languages
English (en)
Inventor
Laurent Miclo
Emanuel Perrin
Alain Driou
Jean-Francois Boudier
Catherine Iung
Guy Linden
Original Assignee
Cooperative Agricole Laitiere
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cooperative Agricole Laitiere filed Critical Cooperative Agricole Laitiere
Publication of GR3030650T3 publication Critical patent/GR3030650T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR990401736T 1994-11-30 1999-06-30 Use of a decapeptide with a benzodiazepine activity for the preparation of medicaments and dietary supplements GR3030650T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9414362A FR2727315A1 (fr) 1994-11-30 1994-11-30 Utilisation d'un decapeptide a activite de type benzodiazepine pour la preparation de medicaments et de complements alimentaires

Publications (1)

Publication Number Publication Date
GR3030650T3 true GR3030650T3 (en) 1999-10-29

Family

ID=9469315

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990401736T GR3030650T3 (en) 1994-11-30 1999-06-30 Use of a decapeptide with a benzodiazepine activity for the preparation of medicaments and dietary supplements

Country Status (10)

Country Link
US (1) US5846939A (el)
EP (1) EP0714910B1 (el)
JP (1) JP3973244B2 (el)
AT (1) ATE178615T1 (el)
DE (1) DE69508890T2 (el)
DK (1) DK0714910T3 (el)
ES (1) ES2135023T3 (el)
FR (1) FR2727315A1 (el)
GR (1) GR3030650T3 (el)
SI (1) SI0714910T1 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465432B1 (en) * 2000-08-28 2002-10-15 Kraft Food Holdings, Inc. Isolated antioxidant peptides form casein and methods for preparing, isolating, and identifying antioxidant peptides
EP1275308A1 (en) * 2001-07-13 2003-01-15 The Procter & Gamble Company Food composition offering stress relaxation to mammals
NL1032322C2 (nl) * 2006-08-15 2008-02-18 Friesland Brands Bv Slaapmelk.
FR2909879B1 (fr) * 2006-12-13 2009-03-13 Lorraine Inst Nat Polytech Utilisation d'un heptapeptide a activite anxiolytique pour la preparation de medicaments et de complements alimentaires
FR2932090B1 (fr) * 2008-06-06 2012-09-14 Lorraine Inst Nat Polytech Compositions anxiolytiques comprenant des peptides derives de la caseine alpha s1
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
CN109310638A (zh) 2016-05-06 2019-02-05 医师印章有限责任公司 缬草组合物和相关方法
US10980269B2 (en) 2016-12-12 2021-04-20 Mead Johnson Nutrition Company Protein hydrolysates and methods of making same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents
JPH06239888A (ja) * 1993-02-18 1994-08-30 Kanebo Ltd 新規ペプチド及び鎮静剤並びに精神安定用食品

Also Published As

Publication number Publication date
ATE178615T1 (de) 1999-04-15
ES2135023T3 (es) 1999-10-16
EP0714910B1 (fr) 1999-04-07
DK0714910T3 (da) 1999-10-18
SI0714910T1 (en) 1999-10-31
JP3973244B2 (ja) 2007-09-12
US5846939A (en) 1998-12-08
EP0714910A1 (fr) 1996-06-05
DE69508890T2 (de) 1999-10-07
FR2727315A1 (fr) 1996-05-31
JPH08268903A (ja) 1996-10-15
FR2727315B1 (el) 1997-02-14
DE69508890D1 (de) 1999-05-12

Similar Documents

Publication Publication Date Title
CA2221455A1 (en) Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
EP0339656A3 (en) Lactalbumin as food supplement
CA2242114A1 (en) Nutritional supplement for the treatment and prevention of excessive intestinal permeability
CA2166003A1 (en) Method for providing nutrition to the elderly patients
CA1268123C (en) DIETARY PRODUCTS CONTAINING METHYLSULFONYLMETHANE AND THEIR USE
IL88898A0 (en) 1,2-bis(aminomethyl)-cyclo-butane-platinum complexes,their preparation and pharmaceutical compositions containing them
ES2168157T3 (es) Alimento o suplemento nutritivo, su procedimiento de preparacion y sus utilizaciones.
PT923315E (pt) Formula nutricional para pacientes com fenilcetonuria
DE69806820D1 (de) Kaloriereiche ernährungszusammensetzung
EP0189160A3 (en) High fat, low carbohydrate enteral nutritional formula
DK0626176T3 (da) Næringsmiddel til personer, som undergår stråleterapi eller kemoterapi
GR3030650T3 (en) Use of a decapeptide with a benzodiazepine activity for the preparation of medicaments and dietary supplements
ATE96327T1 (de) Nahrungsmittelzusatz.
AU8230187A (en) N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration
AU7100094A (en) Rumen-bypass fatty acid salt and protein dietary supplement for ruminants
GB8821188D0 (en) Dietary supplements
HK1025562A1 (en) Solid compositions suitable for oral administration comprising l-carnitine choline tartrate
IL131956A0 (en) Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid
IT8820340A0 (it) Prodotto e apparecchio perl'ottenimento di bevande alimentari medicinali e dietetiche.
Beverly Serum protein fluxes between the vasculature and tissues of the hindlimbs in calves fed soy or urea purified diets
EP0893069A3 (de) Antioxidative Zusammensetzungen mit Süssmolkekonzentrat
Welch The effect of dietary protein concentration on zinc metabolism in ruminant Holstein calves
GAILLARD et al. The effects of marginal vitamin deficiency on mental performance
CA2034145A1 (en) Confectionery product made of protein and carbohydrate materials present in a relative weight ratio higher than 1
IT8920225A0 (it) Integratori dietetici, in particolare per condizioni di accresciuto catabolismo proteico.